“…They divided cardiomyocytes into two groups, including less mature type or developing type (dCMs) with immature cardiomyocyte markers such as Myocd (also known as myocardin) and more mature type (mCMs) with abundant mitochondria and positive for muscle fiber markers such as Actc1 (also known as cardiac α-actin) ( Table 1 ) ( 14 ). Interestingly, some mCMs, such as those in the mCM1, also expressed these fibroblast-enriched markers (e.g., Col1a2, Col3a1, and Dcn), and Gata4 + or Myocd + nuclei were significantly enriched only in dCMs but not in mCMs or nonmyocyte cells.Partially different from the widely established markers of cardiomyocyte proliferation such as nucleotides analogs (EdU, BrdU), M-phase markers AURKB (Aurora B kinase) and pHH3 (phospho-histone H3), this study also entified a small population of presumably proliferating cardiomyocytes (pCMs) that expressed cell cycle genes (e.g., Mki67, Cenpp, and Kif15) ( Table 1 ), and found both P6 and P10 pCMs populations have the same similar gene signatures of cell proliferation: mitosis, G2/M transition, chromosome segregation and cytokinesis ( 14 – 16 ). A similar study explored whether a unique subset of preexisting cardiomyocytes could be regenerated by applying snRNA-seq (single-nucleus RNA sequencing) in healthy, injured and regenerating mice hearts ( 17 ) ( Table 2 ).…”